Disparities in COVID-19 Related Outcomes in the United States By Race and Ethnicity: An Umbrella Review of Meta-Analyses

Author(s)

Duong K1, Le L1, Veettil SK2, Saidoung P1, Wannaadisai W3, Nelson RE4, Friedrichs M5, Jones B6, Visnovsky L4, Pavia A7, Jones M4, Samore M4, Chaiyakunapruk N1
1Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA, 2College of Pharmacy, University of Utah, Salt Lake City, UT, USA, 3Faculty of Pharmacy, Mahidol University, Bangkok, Thailand, 4Division of Epidemiology, School of Medicine, University of Utah, Salt Lake City, UT, USA, 5Utah Department of Health, salt lake city, UT, USA, 6Division of Pulmonary & Critical Care, University of Utah, salt lake city, UT, USA, 7Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City, UT, USA

Presentation Documents

OBJECTIVES:

Meta-analyses have investigated associations between race and ethnicity and COVID-19 outcomes. However, there is uncertainty about these associations' existence, magnitude, and level of evidence. We, therefore, aimed to synthesize, quantify, and grade the strength of evidence of race and ethnicity and COVID-19 outcomes in the US.

METHODS:

In this umbrella review, we searched four databases (Pubmed, Embase, the Cochrane Database of Systematic Reviews, and Epistemonikos) from database inception to April 2022. The methodological quality of each meta-analysis was assessed using the Assessment of Multiple Systematic Reviews, version 2 (AMSTAR-2). The strength of evidence of the associations between race and ethnicity with outcomes was ranked according to established criteria as convincing, highly suggestive, suggestive, weak, or non-significant. The study protocol was registered with PROSPERO, CRD42022336805

RESULTS:

Of 880 records screened, we selected seven meta-analyses for evidence synthesis, with 42 associations examined. Overall, 10 of 42 associations were statistically significant (p ≤ 0·05). Two associations were highly suggestive, two were suggestive, and two were weak, whereas the remaining 32 associations were non-significant. The risk of COVID-19 infection was higher in Black individuals compared to White individuals (risk ratio, 2·08, 95% Confidence Interval (CI), 1·60–2·71), which was supported by highly suggestive evidence; with the conservative estimates from the sensitivity analyses, this association remained suggestive. Among those infected with COVID-19, Hispanic individuals had a higher risk of COVID-19 hospitalization than non-Hispanic White individuals (odds ratio, 2·08, 95% CI, 1·60–2·70) with highly suggestive evidence which remained after sensitivity analyses.

CONCLUSIONS:

Individuals of Black and Hispanic groups had a higher risk of COVID-19 infection and hospitalization. These associations of race and ethnicity and COVID-19 outcomes existed more obviously in the pre-hospitalization stage. More consideration should be given in this stage for addressing health inequity.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

CO14

Topic

Clinical Outcomes, Health Policy & Regulatory

Topic Subcategory

Clinical Outcomes Assessment, Health Disparities & Equity

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×